Tag: Sisu Global Health

Awards

AsclepiX’s Wendy Perrow and Glyscend Among 2017 ICE Winners

AsclepiX’s Wendy Perrow and Glyscend Among 2017 ICE Winners

TEDCO has announced its 2017 ICE award recipients, and two of the six winners have connections to Johns Hopkins. On May 25, AsclepiX CEO Wendy Perrow was named entrepreneur of the year, and Glyscend received an award for innovation.

Perrow began leading the FastForward startup, a therapeutics company based on technology developed by Johns Hopkins Drs. Jordan Green and Aleksander Popel, in the summer of 2016 and currently manages the company’s business, clinical, financial, licensing and corporate development efforts. Prior to AsclepiX, Perrow served as CEO of Alba Therapeutics.

Glyscend’s ICE award marks the second time the company’s non-invasive treatment for type 2 diabetes has received recognition for innovation in the past six months. Glyscend also won Johnson & Johnson Innovation’s World Without Disease Quickfire Challenge, a national competition that awarded them $500,000.

TEDCO created the ICE Awards to honor innovation, corporate excellence and entrepreneurship at its coolest portfolio companies and to recognize the best and brightest entrepreneurs developing cutting-edge technologies and enriching Maryland.

This is the second straight strong showing by Johns Hopkins-backed startups. Sisu Global Health, a startup developing medical devices for emerging markets, won in the innovation category last year. Additionally, Immunomic Therapeutics, a biotechnology company developing an immunomodulation platform that has the platform to transform the allergy and cancer immunotherapy markets, won for corporate excellence.

Interested in investing in a venture? Click here!

 

Startups

Sisu Global Health closing in on $1M seed round

The company that makes a low-cost blood transfusion device received the first investment from a new fund focused on Maryland startups.

In Africa, the team building Sisu Global Health is stepping up the introduction of its blood transfusion device. In Baltimore, the team is posting fundraising gains.

Sisu recently raised $500,000 from the Camden Partners Exelixis Fund, CMO Katie Kirsch said.

It’s the first investment made by the new fund focused on growing companies in Maryland, said Camden’s George Petrocheilos.

Sisu now has $800,000 toward its seed round. Previous investment came from the company’s pitch competition during Steve Case’s Rise of the Rest tour stop in Baltimore last year, and the Abell Foundation. The company is seeking $1 million for the round, Kirsch said.

The company’s three cofounders relocated to Baltimore from Michigan in 2015. They connected with local resources, participating in the Dreamit Health accelerator and working with Harbor Designs and Manufacturing on producing the Hemafuse device. The startup is now based out of Impact Hub Baltimore in Station North.

Kirsch said CTO Gillian Henker is currently in Ethiopia kicking off clinical studies for the device, which offers a safer and more affordable way to give a person a blood transfusion with their own blood.

https://technical.ly/baltimore/2016/09/07/sisu-global-health-camden-partners/

WP-Backgrounds Lite by InoPlugs Web Design and Juwelier Schönmann 1010 Wien